 GAIL India Ltd reports consolidated PAT of Rs. 1972.40 crores in Q2 FY26
GAIL India Ltd reports consolidated PAT of Rs. 1972.40 crores in Q2 FY26 The Phosphate Company Ltd Q2FY26 loss at Rs. 2.48 crore
The Phosphate Company Ltd Q2FY26 loss at Rs. 2.48 crore Emami Paper Mills Ltd Q2 FY2026 profit at Rs. 6.58 crores
Emami Paper Mills Ltd Q2 FY2026 profit at Rs. 6.58 crores Maruti Suzuki India Ltd Q2 FY2026 consolidated PAT slips QoQ to Rs. 3349 crores
Maruti Suzuki India Ltd Q2 FY2026 consolidated PAT slips QoQ to Rs. 3349 crores RattanIndia Power Ltd consolidated Q2FY26 loss at Rs. 31.55 crores
RattanIndia Power Ltd consolidated Q2FY26 loss at Rs. 31.55 crores 
              The Nomination and Remuneration / Compensation committee of Aurobindo Pharma Ltd on March 30, 2017 has allotted 15000 equity shares of Re.1/- each under ESOP of the Company.
Consequent to the allotment, the paid up share capital of the company has increased from 58,58,67,409 equity shares of Rs. 1 each to 58,58,82,409 equity shares of Rs. 1 each.
Shares of AUROBINDO PHARMA LTD. was last trading in BSE at Rs.674.35 as compared to the previous close of Rs. 671.45. The total number of shares traded during the day was 160255 in over 3136 trades.
The stock hit an intraday high of Rs. 681.5 and intraday low of 668.5. The net turnover during the day was Rs. 108416602.